Quantcast

Latest Neonatology Stories

2014-07-29 12:35:21

WARRINGTON, Pa., July 29, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, will report its second quarter 2014 financial results on August 5, 2014 before the open of the U.S. financial markets. The Company will host a live teleconference and webcast at 9:00 a.m. Eastern Time that same day. During the conference call, Discovery Labs' management will discuss the...

2014-07-08 09:44:55

BMJ-British Medical Journal And 50 percent higher for very premature babies born after less than 27 weeks of pregnancy The advantage is particularly evident for very premature babies born after less than 27 weeks of pregnancy, where the figure rises to 50%, prompting the authors to conclude that new services for newborns should promote delivery of very preterm babies in high volume units. How best to organize critical care for newborns has been the focus of intense debate, with the...

2014-06-17 08:29:40

WARRINGTON, Pa., June 17, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO) today announced that it has been awarded the final $1.9 million of a $2.4 million Fast Track Small Business Innovation Research (SBIR) Grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). This award will provide support for the ongoing phase 2a clinical trial for AEROSURF®, Discovery Labs' investigational combination drug/device product....

2014-05-20 12:33:07

- Company Reinforces Commitment to Pipeline Advancement and Scientific Excellence - WARRINGTON, Pa., May 20, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced that it has strengthened its scientific leadership. Effective immediately, Steve Simonson, M.D., M.H.S. has joined the Company as Vice President, Clinical Development, and Lawrence Weinstein has...

2014-05-15 23:07:04

LLUCH is the first hospital in the Inland Empire and only the fourth in California to offer Neuro NICU services. Loma Linda, CA (PRWEB) May 15, 2014 Loma Linda University Children’s Hospital (LLUCH) has opened a Neuro NICU (Neonatal Intensive Care Unit) offering specialized neurological services to babies. LLUCH is the first hospital in the Inland Empire and only the fourth in California to offer such services. “With the opening of the Neuro NICU at Loma Linda University Children’s...

2014-05-07 08:32:19

WARRINGTON, Pa., May 7, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent and Notices of Allowance for patents covering critical aspects of its KL4 surfactant and drug delivery technology platform. The Company announced the issuance of U.S. Patent No. 8,701,658 entitled...

2014-05-06 08:34:07

WARRINGTON, Pa., May 6, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, will report first quarter 2014 financial results on May 8, 2014 before the open of the U.S. financial markets. The Company will host a live teleconference and webcast at 9:00 a.m. Eastern Time that same day. During the conference call, Discovery Labs' management will discuss the 2014 first...

2014-04-21 23:01:53

CHOP Researchers’ Animal Study Suggests that Improving Newborns’ Bacterial Environment Could Fend Off Infections Philadelphia, Pa. (PRWEB) April 21, 2014 Mothers give a newborn baby a gift of germs—germs that help to kick-start the infant’s immune system. But antibiotics, used to fend off infection, may paradoxically interrupt a newborn’s own immune responses, leaving already-vulnerable premature babies more susceptible to dangerous pathogens. A new animal study by neonatology...

2014-03-11 08:29:57

WARRINGTON, Pa., March 11, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, will report fourth quarter 2013 financial results on Thursday, March 13, 2014 before the open of the U.S. financial markets. The Company will host a conference call and live audio webcast at 10:00 a.m. Eastern Time that same day. During the conference call, Discovery Labs' management will...

2014-02-26 16:27:17

AMHERST, N.Y., Feb. 26, 2014 /PRNewswire/ -- ONY, Inc., a pioneer in neonatal pharmaceutical development, has reached an agreement with Recordati Rare Diseases to co-promote NeoProfen(®) (ibuprofen lysine) Injection. (Logo: http://photos.prnewswire.com/prnh/20140226/CL72787LOGO ) NeoProfen® is indicated to close a clinically significant Patent Ductus Arteriosis (PDA) in premature infants weighing between 500 and 1500 grams, who are no more than 32 weeks gestational age when...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related